Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06487585 · ClinicalTrials.gov registry record · Phase 4
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
A Phase 4 study of Vasodilatory Hypotension During or After Cardiac Surgery, sponsored by University of Maryland St. Joseph Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06487585 is a Phase 4 study of Vasodilatory Hypotension During or After Cardiac Surgery that is actively recruiting participants, run by University of Maryland St. Joseph Medical Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06487585, a Phase 4 study of Vasodilatory Hypotension During or After Cardiac Surgery, is actively recruiting participants, sponsored by University of Maryland St. Joseph Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
Conditions Studied
Interventions
- DRUG Angiotensin II
Study Locations (1)
Maryland
- University of Maryland St. Joseph Medical Center - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-06 |
| Est. Completion | 2026-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06487585
The ClinicalTrials.gov registry entry for NCT06487585 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland St. Joseph Medical Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vasodilatory Hypotension During or After Cardiac Surgery appearing as the primary indexed condition, and to 1 intervention - of which Angiotensin II is the first listed.
NCT06487585 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06487585 about?
NCT06487585 is a clinical study titled "ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)". The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
What is the current status of trial NCT06487585?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2025-05-06. Estimated completion is 2026-02.
What conditions does trial NCT06487585 study?
This clinical trial studies the following conditions: Vasodilatory Hypotension During or After Cardiac Surgery.
What interventions are being tested in trial NCT06487585?
The interventions under investigation include: Angiotensin II (DRUG).
Who is sponsoring clinical trial NCT06487585?
This trial is sponsored by University of Maryland St. Joseph Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06487585 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.